Literature DB >> 21840751

Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma.

Chung-Jan Kang1, Chun-Ta Liao, Chuen Hsueh, Li-Yu Lee, Chien-Yu Lin, Kang-Hsing Fan, Hung-Ming Wang, Shiang-Fu Huang, I-How Chen, Shu-Hang Ng, Chung-Kan Tsao, Yu-Chen Huang, Tzu-Chen Yen.   

Abstract

The prognosis of well-differentiated oral cavity squamous cell carcinoma (OSCC) is better than less-well-differentiated neoplasms. The aim of this retrospective study was to identify prognostic factors in patients with well-differentiated OSCC. The 5-year outcomes of 467 patients with well-differentiated OSCC who underwent radical surgery and neck dissection were analyzed. In the entire cohort, the presence of pathological node metastases (pN+ vs. pN0) was an independent predictor of 5-year outcomes. In pN0 patients, tumor depth (≥8 mm) was the only independently prognostic factor for 5-year survival rates on multivariable analysis (disease-free survival [DFS], P=0.001, hazard ratio [HR]=2.634, 95% confidence interval [95% CI]=1.496-4.636; disease-specific survival [DSS], P<0.001, HR=6.794, 95% CI=2.364-19.525). In pN+ patients, level IV/V neck nodal metastases (DFS, P<0.001, HR=47.483, 95% CI=8.942-252.122; DSS, P<0.001, HR=14.301, 95% CI=5.337-38.323), and ≥3 positive nodes (DFS, P=0.037, HR=2.107, 95% CI=1.047-4.242; DSS, P=0.044, HR=2.093, 95% CI=1.020-4.295) were independently associated with 5-year outcomes. Our results suggest that a tailored treatment approach in well-differentiated OSCC patients should take into account the presence of either pN0 or pN+ disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21840751     DOI: 10.1016/j.oraloncology.2011.07.018

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  9 in total

1.  Chronological shifts and changing causes of death after radiotherapy for early-stage oral cancer.

Authors:  Rina Fujisawa; Hitoshi Shibuya; Naoki Harata; Keiko Yuasa-Nakagawa; Kazuma Toda; Keiji Hayashi
Journal:  Int J Clin Oncol       Date:  2013-02-02       Impact factor: 3.402

2.  Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.

Authors:  Anna Farnedi; Silvia Rossi; Nicoletta Bertani; Mariolina Gulli; Enrico Maria Silini; Maria Teresa Mucignat; Tito Poli; Enrico Sesenna; Davide Lanfranco; Lucio Montebugnoli; Elisa Leonardi; Claudio Marchetti; Renato Cocchi; Andrea Ambrosini-Spaltro; Maria Pia Foschini; Roberto Perris
Journal:  BMC Cancer       Date:  2015-05-03       Impact factor: 4.430

3.  Applicability of preoperative nuclear morphometry to evaluating risk for cervical lymph node metastasis in oral squamous cell carcinoma.

Authors:  Masaaki Karino; Eiji Nakatani; Katsumi Hideshima; Yoshiki Nariai; Kohji Tsunematsu; Koichiro Ohira; Takahiro Kanno; Izumi Asahina; Tatsuo Kagimura; Joji Sekine
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

4.  To evaluate disparity between clinical and pathological tumor-node-metastasis staging in oral cavity squamous cell carcinoma patients and its impact on overall survival: An institutional study.

Authors:  Karan Gupta; Naresh K Panda; Jaimanti Bakshi; Ashim Das
Journal:  South Asian J Cancer       Date:  2015 Oct-Dec

5.  Analysis of clinicopathological characteristics associated with the outcome of oral squamous cell carcinoma and the establishment of tissue microarrays.

Authors:  Xin Jin; Dongjuan Liu; Xin Zhao; Yu Zhou; Lu Jiang; Jing Li; Xin Zeng; Qianming Chen
Journal:  Oncol Lett       Date:  2016-09-12       Impact factor: 2.967

6.  MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.

Authors:  Ai-Min Zhang; Xiao-Hui Chi; Zu-Qiang Bo; Xiao-Fang Huang; Jin Zhang
Journal:  Biosci Rep       Date:  2019-09-16       Impact factor: 3.840

7.  Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: a multi-institutional analysis.

Authors:  Han Zhang; Peter T Dziegielewski; Vince L Biron; Jacek Szudek; Khaled H Al-Qahatani; Daniel A O'Connell; Jeffrey R Harris; Hadi Seikaly
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-04-19

8.  The impact of clinical versus pathological staging in oral cavity carcinoma--a multi-institutional analysis of survival.

Authors:  Vincent L Biron; Daniel A O'Connell; Hadi Seikaly
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-04-11

9.  Ordinal logistic regression model describing factors associated with extent of nodal involvement in oral cancer patients and its prospective validation.

Authors:  Vishwajeet Singh; Sada Nand Dwivedi; S V S Deo
Journal:  BMC Med Res Methodol       Date:  2020-04-26       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.